510(k) device
Ensure Single-Use Coagulation Forceps
Micro-Tech (Nanjing) Co., Ltd. · Forceps, Biopsy, Electric (KGE, Class II) · First FDA decision Mar 15, 2021, newest Mar 15, 2021Colorectal cancer and polypsGastrointestinal bleeding
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Ensure Single-Use Coagulation"
MAUDE reports
0
Brand "Ensure Single-Use Coagulation", since 2015
PubMed studies
0
Mentioning "Ensure Single-Use Coagulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ensure Single-Use Coagulation Forceps
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K202438 · Decided Mar 15, 2021 · 202 days after receipt
Device type: Forceps, Biopsy, Electric (KGE) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ensure Single-Use Coagulation", any status and sponsor, newest update first.
The Levine Center for Plastic SurgeryAcademic, hospital or other
NCT07224308 · 20 participants (planned) · Start Oct 24, 2025 · Primary completion Nov 30, 2026
Device: Ultherapy Prime · For: Laxity; Skin
Sites: New York, New York
Massachusetts General HospitalAcademic, hospital or other
NCT04103164 · 10 participants (planned) · Start Jan 15, 2020 · Primary completion Jul 15, 2020
Device: Cutera excel V™ Laser · For: Port-Wine Stain
Sites: Boston, Massachusetts
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ensure Single-Use Coagulation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KGE
173 reports: 134 malfunction, 38 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Ensure Single-Use Coagulation"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code KGE.
- Disposable Hot Biopsy ForcepsMicro-Tech (Nanjing) Co., Ltd. · 510(k) 2018
- Fujifilm Diathermic Slitter (FlushKnife)Fujifilm Medical Systems U.S.A, Inc. · 510(k) 2017
- Single Use Electrosurgical Hemostatic Forceps FD-410LR, FD-411UR, FD-412LROlympus Medical Systems Corp. · 510(k) 2026
- Disposable Hot Biopsy Forceps (FD-210U)Olympus Medical Systems Corporation · 510(k) 2025
- ClearHemograsperFinemedix Co., Ltd. · 510(k) 2025
- Disposable Hot Biopsy ForcepsBeijing Zksk Technology Co., Ltd. · 510(k) 2023
- Diathermic Slitter (FlushKnife) DK2620JI and DK2623JIFujifilm Corporation · 510(k) 2022
- Bipolar Coagulation ForecepsHangzhou AGS MedTech Co., Ltd. · 510(k) 2021
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.